These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 27045125)

  • 1. How Will New Guidelines Affect CD4 Testing in Veterans With HIV?
    Barnett PG; Schmitt SK; Yu W; Goetz MB; Ohl ME; Asch SM
    Clin Infect Dis; 2016 Jul; 63(1):96-100. PubMed ID: 27045125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal frequency of CD4 cell count and HIV RNA monitoring prior to initiation of antiretroviral therapy in HIV-infected patients.
    Kimmel AD; Goldie SJ; Walensky RP; Losina E; Weinstein MC; Paltiel AD; Zhang H; Freedberg KA;
    Antivir Ther; 2005; 10(1):41-52. PubMed ID: 15751762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model for reduced HIV-1 viral load monitoring in resource-limited settings.
    Bryant L; Smith N; Keiser P
    J Int Assoc Provid AIDS Care; 2013; 12(1):67-71. PubMed ID: 22553318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of HIV treatment in seven countries in the WHO Region of the Americas.
    Belaunzarán-Zamudio PF; Caro-Vega YN; Shepherd BE; Crabtree-Ramírez BE; Luz PM; Grinsztejn B; Cesar C; Cahn P; Cortés C; Wolff M; Pape JW; Padgett D; Gotuzzo E; McGowan C; Sierra-Madero JG;
    Bull World Health Organ; 2015 Aug; 93(8):529-39. PubMed ID: 26478610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine CD4 cell count monitoring seldom contributes to clinical decision-making on antiretroviral therapy in virologically suppressed HIV-infected patients.
    Chow EP; Read TR; Chen MY; Fehler G; Bradshaw CS; Fairley CK
    HIV Med; 2015 Mar; 16(3):196-200. PubMed ID: 25236189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
    Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
    Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budget impact analysis of HIV testing in the VA healthcare system.
    Anaya HD; Chan K; Karmarkar U; Asch SM; Bidwell Goetz M
    Value Health; 2012 Dec; 15(8):1022-8. PubMed ID: 23244803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis.
    Bendavid E; Young SD; Katzenstein DA; Bayoumi AM; Sanders GD; Owens DK
    Arch Intern Med; 2008 Sep; 168(17):1910-8. PubMed ID: 18809819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
    Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
    Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
    Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
    Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis.
    Hamers RL; Sawyer AW; Tuohy M; Stevens WS; Rinke de Wit TF; Hill AM;
    AIDS; 2012 Aug; 26(13):1663-72. PubMed ID: 22695297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting HIV care costs using CD4 counts from clinical trials.
    Hill A; Gebo K
    Am J Manag Care; 2007 Sep; 13(9):524-8. PubMed ID: 17803366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.
    Bélec L; Bonn JP
    Future Microbiol; 2011 Nov; 6(11):1251-60. PubMed ID: 22082287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006.
    Krentz HB; Gill MJ
    HIV Med; 2008 Oct; 9(9):721-30. PubMed ID: 18643856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 counts and mortality in virologically suppressed US veterans.
    Drechsler H; Zhang S; Holodniy M; Bedimo R
    J Int Assoc Provid AIDS Care; 2014; 13(2):120-6. PubMed ID: 24378517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.